NCT03336099

Brief Summary

Assessment of the effect of spa treatment on the functional severity of arthrosis. Official title: Evolution of clinical state of patients with rheumatic disease on lower limbs or rachis, 6 months after spa treatment. Primary outcome measure:

  • Measuring the effect of spa treatment on functional severity of arthrosis
  • Proportion of patients with a WOMAC score augmented by 9 or more, 6 months after enrollment (minimal clinically important difference) Secondary outcome measures
  • Quantitative evaluation of pain
  • Comparison of mean Visual Analogue Scale (VAS) pain scale between enrollment and 6 months after
  • Quantitative evaluation of WOMAC
  • Comparison of mean WOMAC between enrollment and 6 months after
  • Impact of spa treatment on the patient's metabolism
  • Height and Weight (BMI calculation)
  • Blood pressure
  • Heart rate
  • Quality of life
  • 36-Item Short Form (SF36) at enrollment, 3 months and 6 months
  • EuroQol 5 Dimensions (EQ5D) questionnaire at enrollment, 3 months and 6 months
  • Opinion of doctor and patient
  • Semi-quantitative scale collected at enrollment, 3 months and 6 months
  • Treatment follow-up
  • Self-evaluation of pain
  • Self-evaluation of pain with VAS pain scale every 6 week

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 29, 2016

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

April 24, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 13, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 13, 2017

Completed
5 months until next milestone

First Posted

Study publicly available on registry

November 8, 2017

Completed
Last Updated

November 8, 2017

Status Verified

November 1, 2017

Enrollment Period

1.2 years

First QC Date

April 24, 2017

Last Update Submit

November 7, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Measuring the effect of spa treatment on functional severity of arthrosis

    Proportion of patients with a WOMAC score augmented by 9 or more, at 6 months compared to baseline (minimal clinically important difference)

    6 months

Secondary Outcomes (11)

  • Quantitative evaluation of pain

    at baseline, 3 and 6 months

  • Quantitative evaluation of WOMAC

    at baseline, 3 and 6 months

  • Patient's BMI

    at baseline, 3 and 6 months

  • Quality of life

    at baseline, 3 and 6 months

  • Quality of life

    at baseline, 3 and 6 months

  • +6 more secondary outcomes

Study Arms (1)

Spa Treatment

EXPERIMENTAL

Bicarbonate and sulfurated water cares in Vals-les-Bains thermal cure center, massage, cataplasm.

Other: Spa Treatment

Interventions

* Bath with immersion shower * Overall shower, penetrating shower * Multiple local application cataplasm * Single local application cataplasm * Inhalation or collective steam bath * Individual physiotherapy technique

Spa Treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient with arthrosis or other rheumatic disease, located on the lower limbs or the rachis
  • Rheumatic indication for spa treatment
  • Diminution of mobility
  • Affiliation to the French social security system or equivalent
  • Available for a 6-months follow-up and an 18-days spa treatment

You may not qualify if:

  • Pregnancy, parturient or breast feeding
  • Psychiatric illness or social situation that would preclude study compliance
  • Contraindication to spa treatment
  • Predictable intolerance to thermal treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thermes de Vals Les Bains

Vals-les-Bains, Ardèche, 07600, France

Location

Related Publications (14)

  • Buskila D, Abu-Shakra M, Neumann L, Odes L, Shneider E, Flusser D, Sukenik S. Balneotherapy for fibromyalgia at the Dead Sea. Rheumatol Int. 2001 Apr;20(3):105-8. doi: 10.1007/s002960000085.

    PMID: 11354556BACKGROUND
  • Constant F, Collin JF, Guillemin F, Boulange M. Effectiveness of spa therapy in chronic low back pain: a randomized clinical trial. J Rheumatol. 1995 Jul;22(7):1315-20.

    PMID: 7562765BACKGROUND
  • Elkayam O, Ophir J, Brener S, Paran D, Wigler I, Efron D, Even-Paz Z, Politi Y, Yaron M. Immediate and delayed effects of treatment at the Dead Sea in patients with psoriatic arthritis. Rheumatol Int. 2000;19(3):77-82. doi: 10.1007/s002960050107.

    PMID: 10776684BACKGROUND
  • Franke A, Reiner L, Pratzel HG, Franke T, Resch KL. Long-term efficacy of radon spa therapy in rheumatoid arthritis--a randomized, sham-controlled study and follow-up. Rheumatology (Oxford). 2000 Aug;39(8):894-902. doi: 10.1093/rheumatology/39.8.894.

    PMID: 10952746BACKGROUND
  • Huskisson EC. Measurement of pain. Lancet. 1974 Nov 9;2(7889):1127-31. doi: 10.1016/s0140-6736(74)90884-8. No abstract available.

    PMID: 4139420BACKGROUND
  • Konrad K, Tatrai T, Hunka A, Vereckei E, Korondi I. Controlled trial of balneotherapy in treatment of low back pain. Ann Rheum Dis. 1992 Jun;51(6):820-2. doi: 10.1136/ard.51.6.820.

    PMID: 1535495BACKGROUND
  • Leplege A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998 Nov;51(11):1013-23. doi: 10.1016/s0895-4356(98)00093-6.

    PMID: 9817119BACKGROUND
  • Neumann L, Sukenik S, Bolotin A, Abu-Shakra M, Amir M, Flusser D, Buskila D. The effect of balneotherapy at the Dead Sea on the quality of life of patients with fibromyalgia syndrome. Clin Rheumatol. 2001;20(1):15-9. doi: 10.1007/s100670170097.

    PMID: 11254234BACKGROUND
  • Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis. 2005 Jan;64(1):34-7. doi: 10.1136/ard.2004.023028. Epub 2004 May 6.

    PMID: 15130902BACKGROUND
  • van Tubergen A, Landewe R, van der Heijde D, Hidding A, Wolter N, Asscher M, Falkenbach A, Genth E, The HG, van der Linden S. Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum. 2001 Oct;45(5):430-8. doi: 10.1002/1529-0131(200110)45:53.0.co;2-f.

    PMID: 11642642BACKGROUND
  • Van Tubergen A, Boonen A, Landewe R, Rutten-Van Molken M, Van Der Heijde D, Hidding A, Van Der Linden S. Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum. 2002 Oct 15;47(5):459-67. doi: 10.1002/art.10658.

    PMID: 12382292BACKGROUND
  • Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Knipschild PG. Balneotherapy for rheumatoid arthritis and osteoarthritis. Cochrane Database Syst Rev. 2000;(2):CD000518. doi: 10.1002/14651858.CD000518.

    PMID: 10796385BACKGROUND
  • Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.

    PMID: 1593914BACKGROUND
  • Forestier R, Desfour H, Tessier JM, Francon A, Foote AM, Genty C, Rolland C, Roques CF, Bosson JL. Spa therapy in the treatment of knee osteoarthritis: a large randomised multicentre trial. Ann Rheum Dis. 2010 Apr;69(4):660-5. doi: 10.1136/ard.2009.113209. Epub 2009 Sep 3.

    PMID: 19734131BACKGROUND

MeSH Terms

Conditions

Osteoarthritis, KneePain

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ludovic BACONNIER

    Ardèche Méridionale Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2017

First Posted

November 8, 2017

Study Start

March 29, 2016

Primary Completion

June 13, 2017

Study Completion

June 13, 2017

Last Updated

November 8, 2017

Record last verified: 2017-11

Data Sharing

IPD Sharing
Will not share

Locations